DCF Tool

CHCT

Community Healthcare Trust Inc – Other Financial Vehicles
Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in its target sub-markets throughout the United States. The Company had investments of approximately $735.4 millionin 141 real estate properties as of December 31, 2020, located in 33 states, totaling approximately 3.1 million square feet.
Analysis Results
Intrinsic Value $171.15
Latest Price $32.53
Relative Value 81% undervalued
Thoughts on this result? Let us know.
Ad
Cash Flow (Millions)
Analysis Parameters
%
%
%
New Ticker
Ad
Analysis Details
Growth Rate Projection

An exponential growth model was fit to the past cash flow data, giving more weight to more recent years. This model determined a growth rate estimate of 24.5%.

Weighted Average Cost of Capital (WACC)

The calculated WACC is 6.0%. This value is used as the default discount rate.

Value of Future Flows

Assuming a growth rate of 24.5%, the cash flows for the next 5 years are projected.

The present value of each year's flow is adjusted to present value using the discount rate.

Year Future flow (million) Present value (million)
2023 89.8 84.8
2024 112 99.6
2025 139 117
2026 173 137
2027 216 161
Terminal Value

Assuming a growth rate after the projection years of 2.0%, the terminal value of the company would be 5530 million. This corresponds to a present value of 3900 million.

Intrinsic Value Per Share

The total present value of the projected cash flows is 600 million. Adding in the terminal value gives a total present value of 4500 million.

There are presently 26.3 million outstanding shares, so the intrinsic value per share is 171.15.

Financial Statements

The following data was to determine the past cash flows.

Current Assets 63,026,000
Current Cash 0
Current Liabilities 20,996,000
Current Debt 0
Non-Cash Working Capital (NCWC) 42,030,000
Change in NCWC 15,170,000
EBIT 33,867,000
Tax Provision 41,000
Depreciation and Amortization 32,339,000
Capital Expenditure -10,376,000
Unlevered Free Cash Flow 70,937,055
Current Assets 43,136,000
Current Cash 0
Current Liabilities 16,276,000
Current Debt 0
Non-Cash Working Capital (NCWC) 26,860,000
Change in NCWC 11,503,000
EBIT 32,907,000
Tax Provision 167,000
Depreciation and Amortization 30,401,000
Capital Expenditure -7,219,000
Unlevered Free Cash Flow 67,349,470
Current Assets 28,450,000
Current Cash 0
Current Liabilities 13,093,000
Current Debt 0
Non-Cash Working Capital (NCWC) 15,357,000
Change in NCWC -15,336,000
EBIT 27,924,000
Tax Provision 80,000
Depreciation and Amortization 25,378,000
Capital Expenditure -6,995,000
Unlevered Free Cash Flow 30,854,388
Current Assets 34,299,000
Current Cash 0
Current Liabilities 3,606,000
Current Debt 0
Non-Cash Working Capital (NCWC) 30,693,000
Change in NCWC 586,000
EBIT 18,670,000
Tax Provision 1,430,000
Depreciation and Amortization 22,225,000
Capital Expenditure -4,372,000
Unlevered Free Cash Flow 34,386,370
Current Assets 33,303,000
Current Cash 0
Current Liabilities 3,196,000
Current Debt 0
Non-Cash Working Capital (NCWC) 30,107,000
Change in NCWC 2,581,000
EBIT 13,440,000
Tax Provision -1,547,000
Depreciation and Amortization 20,168,000
Capital Expenditure -4,557,000
Unlevered Free Cash Flow 31,632,000
Current Assets 31,582,000
Current Cash 0
Current Liabilities 4,056,000
Current Debt 0
Non-Cash Working Capital (NCWC) 27,526,000
Change in NCWC 15,391,000
EBIT 7,387,000
Tax Provision 0
Depreciation and Amortization 18,153,000
Capital Expenditure -1,132,000
Unlevered Free Cash Flow 39,799,000
Current Assets 15,676,000
Current Cash 0
Current Liabilities 3,541,000
Current Debt 0
Non-Cash Working Capital (NCWC) 12,135,000
Change in NCWC -1,252,000
EBIT 3,869,000
Tax Provision 0
Depreciation and Amortization 13,383,000
Capital Expenditure -1,579,000
Unlevered Free Cash Flow 14,421,000

This analysis is provided for informational purposes only and does not constitute financial or investing advice. For more information on the advantages and limitations of DCF analysis see background. This information is provided on an "as is" basis. No warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, legality, reliability or usefulness of any information. By using this site you agree that under no circumstances shall Valuation Tools LLC be held liable for any loss or damage caused by information obtained from this website including any articles, data, videos, its social media accounts, or any other materials.